• Je něco špatně v tomto záznamu ?

Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review

J. Kopecký, P. Trojanová, O. Kubeček, O. Kopecký,

. 2015 ; 45 (4) : 381-4.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc15022866

Recently, new drugs targeting the immune system have been introduced to the standard care of metastatic malignant melanoma. One of these immunomodulatory drugs is ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4. The following case reports on a 54-year-old man with metastatic melanoma, who developed Grade 4 thrombocytopenia during treatment with ipilimumab already after first dose. Bone marrow examination confirmed a diagnosis of drug-induced, immune-mediated thrombocytopenia. Isolated thrombocytopenia has rarely been associated with ipilimumab and there is no standard treatment algorithm of such complication. This case demonstrates the importance of monitoring full blood count in all patients receiving ipilimumab and suggests a possible treatment algorithm.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15022866
003      
CZ-PrNML
005      
20170110103954.0
007      
ta
008      
150709s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/jjco/hyu222 $2 doi
035    __
$a (PubMed)25583422
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kopecký, Jindřich $u Department of Clinical Oncology and Radiotherapy, University Hospital in Hradec Králové, Hradec Králové kopecjin@fnhk.cz.
245    10
$a Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review / $c J. Kopecký, P. Trojanová, O. Kubeček, O. Kopecký,
520    9_
$a Recently, new drugs targeting the immune system have been introduced to the standard care of metastatic malignant melanoma. One of these immunomodulatory drugs is ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4. The following case reports on a 54-year-old man with metastatic melanoma, who developed Grade 4 thrombocytopenia during treatment with ipilimumab already after first dose. Bone marrow examination confirmed a diagnosis of drug-induced, immune-mediated thrombocytopenia. Isolated thrombocytopenia has rarely been associated with ipilimumab and there is no standard treatment algorithm of such complication. This case demonstrates the importance of monitoring full blood count in all patients receiving ipilimumab and suggests a possible treatment algorithm.
650    _2
$a hormony kůry nadledvin $x terapeutické užití $7 D000305
650    _2
$a monoklonální protilátky $x škodlivé účinky $7 D000911
650    _2
$a antitumorózní látky $x škodlivé účinky $7 D000970
650    _2
$a lidé $7 D006801
650    _2
$a intravenózní imunoglobuliny $x terapeutické užití $7 D016756
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melanom $x farmakoterapie $x sekundární $7 D008545
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory kůže $x farmakoterapie $x sekundární $7 D012878
650    _2
$a trombocytopenie $x chemicky indukované $x farmakoterapie $7 D013921
650    _2
$a výsledek terapie $7 D016896
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Trojanová, Petronela $u Department of Clinical Oncology and Radiotherapy, University Hospital in Hradec Králové, Hradec Králové
700    1_
$a Kubeček, Ondřej $u Department of Clinical Oncology and Radiotherapy, University Hospital in Hradec Králové, Hradec Králové $7 xx0209606
700    1_
$a Kopecký, Otakar $u Department of Clinical Immunology and Microbiology, Regional Hospital Náchod, Náchod, Czech Republic.
773    0_
$w MED00002442 $t Japanese journal of clinical oncology $x 1465-3621 $g Roč. 45, č. 4 (2015), s. 381-4
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25583422 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20170110104051 $b ABA008
999    __
$a ok $b bmc $g 1083205 $s 905859
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 45 $c 4 $d 381-4 $i 1465-3621 $m Japanese journal of clinical oncology $n Jpn J Clin Oncol $x MED00002442
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Možnosti archivace